Glipizide
- Product NDC
- 82804-959
- 11-digit product format
- 828040959
- Labeler code
- 82804
- Product ID
- 82804-959_f5d7a98c-d1d4-43b9-8d7e-830a33ae0c24
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Glipizide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Proficient Rx LP
- Application
- ANDA074378
- Marketing category
- ANDA
- Marketing start
- 2025-05-01
- Substance
- GLIPIZIDE
- Active strength
- 5 mg/1
- Pharmacologic classes
- Sulfonylurea Compounds [CS], Sulfonylurea [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Glipizide
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| GLIPIZIDE | 5 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | X7WDT95N5C |
| Rxcui | 310488, 310490 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 82804-959-00 | 82804095900 | 100 TABLET in 1 BOTTLE (82804-959-00) | 100 tablet | 2026-01-12 | No | No | Current |
| 82804-959-11 | 82804095911 | 1000 TABLET in 1 BOTTLE (82804-959-11) | 1000 tablet | 2026-01-12 | No | No | Current |
| 82804-959-30 | 82804095930 | 30 TABLET in 1 BOTTLE (82804-959-30) | 30 tablet | 2026-01-12 | No | No | Current |
| 82804-959-55 | 82804095955 | 500 TABLET in 1 BOTTLE (82804-959-55) | 500 tablet | 2026-01-12 | No | No | Current |
| 82804-959-60 | 82804095960 | 60 TABLET in 1 BOTTLE (82804-959-60) | 60 tablet | 2026-01-12 | No | No | Current |
| 82804-959-72 | 82804095972 | 120 TABLET in 1 BOTTLE (82804-959-72) | 120 tablet | 2026-01-12 | No | No | Current |
| 82804-959-90 | 82804095990 | 90 TABLET in 1 BOTTLE (82804-959-90) | 90 tablet | 2026-01-12 | No | No | Current |